Universe Pharmaceuticals INC Statistics
Share Statistics
Universe Pharmaceuticals INC has 216.53K
shares outstanding. The number of shares has increased by -0.24%
in one year.
| Shares Outstanding | 216.53K |
| Shares Change (YoY) | -0.24% |
| Shares Change (QoQ) | -0.05% |
| Owned by Institutions (%) | 0.47% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 2 |
| FTD / Avg. Volume | n/a |
Short Selling Information
The latest short interest is 74.8K, so 0.49% of the outstanding
shares have been sold short.
| Short Interest | 74.8K |
| Short % of Shares Out | 0.49% |
| Short % of Float | 0.5% |
| Short Ratio (days to cover) | 1 |
Valuation Ratios
| PE Ratio | 0 |
| Forward PE | n/a |
| PS Ratio | 0 |
| Forward PS | n/a |
| PB Ratio | 0 |
| P/FCF Ratio | 0 |
| PEG Ratio | 0 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for Universe Pharmaceuticals INC.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.54,
with a Debt / Equity ratio of 0.18.
| Current Ratio | 2.54 |
| Quick Ratio | 2.46 |
| Debt / Equity | 0.18 |
| Debt / EBITDA | -1.09 |
| Debt / FCF | -0.81 |
| Interest Coverage | -28.83 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $102,330.92 |
| Profits Per Employee | $-38,787.99 |
| Employee Count | 225 |
| Asset Turnover | 0.34 |
| Inventory Turnover | 9.76 |
Taxes
| Income Tax | 606.7K |
| Effective Tax Rate | -7.47% |
Stock Price Statistics
The stock price has increased by -99.66% in the
last 52 weeks. The beta is 1.53, so Universe Pharmaceuticals INC's
price volatility has been higher than the market average.
| Beta | 1.53 |
| 52-Week Price Change | -99.66% |
| 50-Day Moving Average | 4.27 |
| 200-Day Moving Average | 363.56 |
| Relative Strength Index (RSI) | 57.43 |
| Average Volume (20 Days) | 528,311 |
Income Statement
In the last 12 months, Universe Pharmaceuticals INC had revenue of 23.02M
and earned -8.73M
in profits. Earnings per share was 0.
| Revenue | 23.02M |
| Gross Profit | 6.07M |
| Operating Income | -8.02M |
| Net Income | -8.73M |
| EBITDA | -7.36M |
| EBIT | -7.84M |
| Earnings Per Share (EPS) | 0 |
Full Income StatementBalance Sheet
The company has 29.5M in cash and 7.99M in
debt, giving a net cash position of 21.5M.
| Cash & Cash Equivalents | 29.5M |
| Total Debt | 7.99M |
| Net Cash | 21.5M |
| Retained Earnings | -10.17M |
| Total Assets | 67.95M |
| Working Capital | 31.32M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -9.51M
and capital expenditures -363.09K, giving a free cash flow of -9.87M.
| Operating Cash Flow | -9.51M |
| Capital Expenditures | -363.09K |
| Free Cash Flow | -9.87M |
| FCF Per Share | 0 |
Full Cash Flow StatementMargins
Gross margin is 26.37%, with operating and profit margins of -34.83% and -37.9%.
| Gross Margin | 26.37% |
| Operating Margin | -34.83% |
| Pretax Margin | -35.27% |
| Profit Margin | -37.9% |
| EBITDA Margin | -31.95% |
| EBIT Margin | -34.83% |
| FCF Margin | -42.87% |
